News & Analysis as of

Health law-news Professional Malpractice

Read need-to-know updates, commentary, and analysis on Health issues written by leading professionals.
Robinson+Cole Data Privacy + Security Insider

Hospitals + Critical Infrastructure Organizations on Alert During Iran Conflict

The American Hospital Association (AHA) is advising hospitals and healthcare entities to “take precautionary measures in case Iran, its proxies or self-radicalized individuals attempt attacks in the U.S.” during the conflict...more

K&L Gates LLP

A Closer Look at HHS's RFI on Accelerating the Adoption of AI in Clinical Care

K&L Gates LLP on

In this episode, Limo Cherian, Rebecca Schaefer, and Clarita Sullivan break down the Department of Health and Human Services’ (HHS) recent Request for Information on Accelerating the Adoption and Use of Artificial...more

Troutman Pepper Locke

New York AG Settles Ghost Network Investigation

Troutman Pepper Locke on

New York Attorney General (AG) Letitia James reached a $2.5 million settlement with health insurer EmblemHealth following an investigation of the behavioral health provider “ghost networks.” “Ghost networks” are provider...more

Holland & Knight LLP

Proposed Illinois Bills Could Unwind Restructuring Deadline for ABA Businesses

Holland & Knight LLP on

Recently proposed legislation in the Illinois General Assembly – Senate Bill (SB) 3807 and House Bill (HB) 5171 – is garnering attention. Both bills hit the docket in February 2026 and aim to alleviate corporate practice...more

Sheppard

CMS CY 2027 Advance Notice Includes Flat Rate Increase And Modified Methodologies

Sheppard on

On January 26, 2026, CMS released the Advance Notice of Methodological Changes for Calendar Year (“CY”) 2027 for Medicare Advantage (“MA”) Capitation Rate and Part C and Part D Payment Policies (the “Advance Notice”). In the...more

Baker Donelson

CMS Signals Expanded Anti-Fraud Enforcement Through CRUSH Initiative

Baker Donelson on

The Centers for Medicare and Medicaid Services (CMS) issued a Request for Information (RFI) on February 27, 2026, that signals a potential expansion of federal health care fraud, waste, and abuse enforcement. While the RFI...more

Goodwin

Fifth Circuit Adopts Narrow Interpretation of Two Critical DEA Regulations

Goodwin on

On February 13, 2026, the Fifth Circuit issued a unanimous panel opinion holding that the Drug Enforcement Agency (“DEA”) misinterpreted two of its pivotal regulations — its “corresponding responsibility” (21 C.F.R. §...more

Kelley Drye & Warren LLP

When Performance Management Meets Age Bias Claims: Lessons From Chreky v. University of Pittsburgh Physicians

Health care executives often struggle to address declining performance in their long tenured or late career physicians. There is the delicate issue of physician pride and ego....more

Holland & Knight LLP

New York Bill Would Create Liability for Chatbot Proprietors Offering Professional Advice

Holland & Knight LLP on

The New York State Senate has advanced a bill that would bar "proprietors" of artificial intelligence (AI)-powered chatbots from providing "substantive" responses or advice that, if provided by a human, would constitute the...more

Bass, Berry & Sims PLC

OCR Launches Part 2 Civil Enforcement Program

On February 13, the Department of Health and Human Services Office for Civil Rights (OCR) announced a new program to implement and enforce federal requirements that protect the confidentiality of substance use disorder (SUD)...more

Ropes & Gray LLP

Black boxes, white coats and red tape: Regulating the use of AI in drug development

Ropes & Gray LLP on

AI systems are being used throughout the medicines lifecycle to analyse large volumes of data. These systems often rely on complex, opaque model architectures that autonomously train on large data sets, presenting unique...more

Seyfarth Shaw LLP

The Week in Weed: March 2026

Seyfarth Shaw LLP on

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana. This week, Louisiana explores a pilot program for adult-use cannabis. Kansas lawmakers introduce bills to legalize...more

Goldberg Segalla

NYC Employers: Changes to NYC Earned Safe and Sick Time Act Require Prompt Action

Goldberg Segalla on

Expansion of New York City’s Earned Safe and Sick Time Act (ESSTA) – previously reported here – became effective February 22. The ESSTA now incorporates the Temporary Schedule Change Act, and the burden on employers to comply...more

Morgan Lewis - As Prescribed

The Impact of the EU Pharma Package on the UK

As readers will be aware, at the end of 2025, the EU institutions agreed the text of the EU Pharma Package: the wholesale change to the pharmaceutical regime in the EU that has been debated for many years. The changes...more

Ogletree, Deakins, Nash, Smoak & Stewart,...

PBM Reforms May Open a New Era for Group Health Plan Sponsors

The federal Consolidated Appropriations Act of 2026 (CAA 2026) and recent regulatory developments could potentially dramatically overhaul reporting and disclosure requirements for pharmacy benefit managers (PBMs) and give new...more

Quarles & Brady LLP

340B Program Alert: Federal Court Ruling Vacates HRSA Notice Related to Child Site Registration Requirements

Quarles & Brady LLP on

On March 3, 2026, the U.S. District Court for the District of Columbia (“Court”) issued a seismic ruling effectively vacating several components of Health Resources and Services Administration’s (“HRSA”) 340B registration...more

Hogan Lovells

UK government guidance on equality action plans

Hogan Lovells on

Under the Employment Rights Act 2025, employers with 250 or more employees will need to prepare equality action plans alongside gender pay gap reports. Action plans are voluntary for gender pay gap reports due in April 2027...more

Epstein Becker & Green

DOGE's Attempt to Crowdsource Medicaid Fraud Scrutiny: Is This the Future of Healthcare Fraud Investigations?

On Friday February 13, 2026, the Department of Government Efficiency (“DOGE”) unit working within the U.S. Department of Health and Human Services (“HHS”) released to the public...more

Goodwin

FDA Accepts Dr. Reddy’s Laboratories’ BLA for Abatacept Biosimilar

Goodwin on

Dr. Reddy’s Laboratories (“Dr. Reddy’s”) announced on February 22 that the FDA accepted its BLA for DRL_AB, a proposed interchangeable biosimilar to Bristol-Myers Squibb’s ORENCIA® (abatacept) IV for infusion. ...more

Gordon Rees Scully Mansukhani

Ultra Processed Food (UPF) Litigation Lands in Mississippi

Ultra-processed food (UPF) litigation has officially arrived in Mississippi. Earlier this month, a 174-page complaint was filed in the Southern District of Mississippi alleging that a number of major consumer defendants...more

Katten Muchin Rosenman LLP

8 Things to Know About CMS’s Nationwide Moratorium on DMEPOS Medical Supply Companies

On February 27, 2026, the Centers for Medicare & Medicaid Services (CMS) published a Notice that it is using its ACA-provided authority to impose a temporary (six-month) nationwide moratorium on the Medicare enrollment of...more

Rothwell, Figg, Ernst & Manbeck, P.C.

Target Acquired, Protein Deleted: The Next Frontier in Precision Medicine and IP Strategy – March 2026 Update

Targeted protein degradation (TPD) has moved from promising concept to near-commercial reality in under a decade. By hijacking the cell’s ubiquitin-proteasome system, TPD therapies eliminate disease-driving proteins entirely...more

ArentFox Schiff

FDA Announces a Single Pivotal Trial as the New Default Standard for Drug Approval

ArentFox Schiff on

On February 19, the US Food and Drug Administration (FDA) announced a significant shift in its drug approval framework: A single adequate and well-controlled clinical trial, combined with confirmatory evidence, will now serve...more

Shumaker, Loop & Kendrick, LLP

Client Alert: Buying and Selling Florida Health Care Entities

Health care transactions are complicated and fraught with potential pitfalls; conducting these transactions in Florida presents its own unique challenges. This article addresses only health care law issues and is not intended...more

King & Spalding

Second Circuit Reaffirms Rule 9(b) Particularity Standard in FCA Action

King & Spalding on

On February 24, 2026, the Second Circuit affirmed the Eastern District of New York’s dismissal of a qui tam action brought against Siemens Medical Solutions USA, Inc. (“Siemens”). The relator alleged that Siemens delivered...more

61,414 Results
 / 
View per page
Page: of 2,457

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide